Bill Sponsors: US HB4242 | 2023-2024 | 118th Congress

Bill Title: To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.

Spectrum: Slight Partisan Bill (Republican 2-1)

Status: (Introduced) 2023-06-23 - Referred to the Subcommittee on Health. [HB4242 Detail]

Text: Latest bill text (Introduced) [PDF]

Sponsors

NameTypeSponsorshipDistrictFinancialFinancialEncyclopediaBiographyBioGuide
Representative Dan Crenshaw [R]PrimarySponsored BillsHD-TX-2OpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide
Representative Mariannette Miller-Meeks [R]CosponsorSponsored BillsHD-IA-1OpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide
Representative Ro Khanna [D]CosponsorSponsored BillsHD-CA-17OpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide

Social Comments on US HB4242

feedback